In this phase, pharmacokinetics takes center stage. A drug might work in a petri dish, but can it survive the acidic environment of the stomach? Will it cross the blood-brain barrier?
Instead of studying a single target, QSP integrates computational models of disease pathways (e.g., the JAK-STAT, NF-kB, and apoptosis networks). This allows prediction of drug effects on entire biological systems, reducing reliance on animal models. For autoimmune diseases, QSP predicts how modulating IL-23 will affect downstream IL-17 and TNF-alpha without triggering opportunistic infections. pharmacology in drug discovery and development
Are you a student or professional in the life sciences? What’s the biggest challenge you’ve seen in translating PD/PK data from the bench to the bedside? Let me know in the comments below. In this phase, pharmacokinetics takes center stage